• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Medical Equipment/Devices
  • Sub-Industry: Life Science Equipment


151.6100 USD 2.0800 1.35%

As of 10:59:32 ET on 04/24/2014.

Snapshot for Illumina Inc (ILMN)

Open: 154.0700 Day's Range: 146.7900 - 155.0000 Volume: 1,180,132
Previous Close: 153.6900 52wk Range: 61.7925 - 183.3000 1-Yr Rtn: +142.39%

Stock Chart for ILMN

No chart data available.
  • ILMN:US 151.8600
  • 1D
  • 1M
  • 1Y
Interactive ILMN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ILMN

Current P/E Ratio (ttm) 86.1204
Estimated P/E(12/2014) 69.8269
Relative P/E vs. SPX 5.1362
Earnings Per Share (USD) (ttm) 1.7234
Est. EPS (USD) (12/2014) 2.1370
Est. PEG Ratio 3.5838
Market Cap (M USD) 19,053.27
Shares Outstanding (M) 128.37
30 Day Average Volume 2,462,683
Price/Book (mrq) 12.3734
Price/Sale (ttm) 12.6914
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 07/23/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ILMN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ILMN

Illumina, Inc. develops, manufactures and markets integrated systems for the large scale analysis of genetic variation and biological function. The Company provides a comprehensive line of products and services that currently serve the sequencing, genotyping and gene expression markets for genomic research centers, pharmaceutical companies, academic institutions and biotechnology companies.

Jay T FlatleyChief Executive OfficerFrancis A DesouzaPresident
Marc A StapleySenior VP/CFOMostafa RonaghiSenior VP/CTO
More Company Profile & Key Executives for ILMN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil